Edwards Lifesciences EW
NYSE EW
$84.40 -2.37 (-2.73%)
As of: Sep 11, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) Total Debt Growth (5y) (2014 - 2026)

Analysis

Edwards Lifesciences (EW) Total Debt Growth (5y) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn
10 Zimmer Biomet Holdings 18.00 Bn 17.59 Bn 1.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11%
Mar 31, 2026 0.11%
Dec 31, 2025 0.11%
Sep 30, 2025 0.11%
Jun 30, 2025 0.11%
Mar 31, 2025 0.11%
Dec 31, 2024 0.11%
Sep 30, 2024 0.11%
Jun 30, 2024 0.11%
Mar 31, 2024 0.11%
Dec 31, 2023 0.11%
Sep 30, 2023 -12.94%
Jun 30, 2023 -12.94%
Mar 31, 2023 -10.77%
Dec 31, 2022 -10.47%
Sep 30, 2022 -11.13%
Jun 30, 2022 -10.13%
Mar 31, 2022 -6.81%
Dec 31, 2021 -6.24%
Sep 30, 2021 -0.17%